Senseonics Holdings, Inc. Common Stock (SENS) is a publicly traded Healthcare sector company. As of July 9, 2026, SENS trades at $5.33 with a market cap of $278.24M and a P/E ratio of -3.26. SENS moved -0.28% today. Year to date, SENS is -3.80%; over the trailing twelve months it is -46.39%. Its 52-week range spans $4.79 to $28.00. Analyst consensus is buy with an average price target of $17.00. Rallies surfaces SENS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Glucotrack Secures Milestone for Implantable CGM, Boosts Shares 1.7%: Glucotrack shares jumped 1.7% after clearing a key development milestone toward commercializing its implantable continuous glucose monitor, while Senseonics shares slipped 0.4% on competitive concerns. The milestone positions Glucotrack to advance regulatory filings and begin scaling manufacturing ahead of a planned launch.
| Metric | Value |
|---|---|
| Price | $5.33 |
| Market Cap | $278.24M |
| P/E Ratio | -3.26 |
| EPS | $-1.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.00 |
| 52-Week Low | $4.79 |
| Volume | 577.68K |
| Avg Volume | 0 |
| Revenue (TTM) | $40.71M |
| Net Income | $-87.19M |
| Gross Margin | 52.07% |
7 analysts cover SENS: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.00.